Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PARA ET PHARMACIE AVALLONNAISE : revenue, balance sheet and financial ratios

PARA ET PHARMACIE AVALLONNAISE is a French company founded 8 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in AVALLON (89200), this company of category PME shows in 2024 a net income positive of 171 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PARA ET PHARMACIE AVALLONNAISE (SIREN 838196137)
Indicator 2024 2023 2022 2021 2020 2018
Revenue N/C N/C N/C N/C N/C N/C
Net income 171 298 € 163 896 € 212 618 € 229 888 € 196 649 € 73 272 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PARA ET PHARMACIE AVALLONNAISE generates positive net income of 171 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 73 k€ -> 171 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

171 298 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 589%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

588.954%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

12.413%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

27.1%

Solvency indicators evolution
PARA ET PHARMACIE AVALLONNAISE

Sector positioning

Debt ratio
588.95 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average +17 pts over 3 years

In 2024, the debt ratio of PARA ET PHARMACIE AVALLON... (588.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
12.41% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch -20 pts over 3 years

In 2024, the financial autonomy of PARA ET PHARMACIE AVALLON... (12.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 135.99. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

135.987

Liquidity indicators evolution
PARA ET PHARMACIE AVALLONNAISE

Sector positioning

Liquidity ratio
135.99 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average -36 pts over 3 years

In 2024, the liquidity ratio of PARA ET PHARMACIE AVALLON... (135.99) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of PARA ET PHARMACIE AVALLONNAISE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PARA ET PHARMACIE AVALLONNAISE is estimated at 2 391 446 € (range 1 665 365€ - 3 577 741€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1665k€ 2391k€ 3577k€
2 391 446 € Range: 1 665 365€ - 3 577 741€
NAF 5 année 2024

Valuation method used

Net Income Multiple
171 298 € × 14.0x = 2 391 447 €
Range: 1 665 366€ - 3 577 741€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PARA ET PHARMACIE AVALLONNAISE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PARA ET PHARMACIE AVALLONNAISE

What is the revenue of PARA ET PHARMACIE AVALLONNAISE ?

The revenue of PARA ET PHARMACIE AVALLONNAISE is not publicly disclosed (confidential accounts filed with INPI).

Is PARA ET PHARMACIE AVALLONNAISE profitable?

Yes, PARA ET PHARMACIE AVALLONNAISE generated a net profit of 171 k€ in 2024.

Where is the headquarters of PARA ET PHARMACIE AVALLONNAISE ?

The headquarters of PARA ET PHARMACIE AVALLONNAISE is located in AVALLON (89200), in the department Yonne.

Where to find the tax return of PARA ET PHARMACIE AVALLONNAISE ?

The tax return of PARA ET PHARMACIE AVALLONNAISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PARA ET PHARMACIE AVALLONNAISE operate?

PARA ET PHARMACIE AVALLONNAISE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.